Amblyopia (Lazy-eye) affects 3% of all population and puts the patients at risk for eventual vision loss.
Gold Standard treatment for lazy eye is placing a patch over the strong eye – an archaic solution which suffers from very low compliance.
With the CureSight™ binocular treatment, children develop stereoscopic vision, which is difficult to be achieved with the monocular nature of the traditional patching treatment.
The CureSight™ system monitors the treatment effect on the child in real-time and performs auto-adjustment of the treatment protocol, relying on AI and big data analysis. The system generates progress reports directly to the eye-care givers and parents via our dedicated application.
Significant improvement in visual acuity and stereoacuity
Compliance of 95% with CureSight™